Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin
出版年份 2010 全文链接
标题
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin
作者
关键词
-
出版物
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 10, Issue 4, Pages 509-519
出版商
Informa UK Limited
发表日期
2010-05-14
DOI
10.1586/erm.10.22
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- The Akt kinases: Isoform specificity in metabolism and cancer
- (2011) Eva Gonzalez et al. CELL CYCLE
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
- (2009) A. Vazquez-Martin et al. ANNALS OF ONCOLOGY
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Concurrent and Sequential Administration of Chemotherapy and the Mammalian Target of Rapamycin Inhibitor Temsirolimus in Human Cancer Cells and Xenografts
- (2009) A. S. Fung et al. CLINICAL CANCER RESEARCH
- Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo
- (2009) S. Landskroner-Eiger et al. CLINICAL CANCER RESEARCH
- Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer
- (2009) M. S. Denzel et al. CLINICAL CANCER RESEARCH
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Targeting the IGF1 axis in cancer proliferation
- (2009) Ilan Bruchim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- mTOR in renal cell cancer: modulator of tumor biology and therapeutic target
- (2009) Piotr J Wysocki EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- LKB1 and Mammalian Target of Rapamycin As Predictive Factors for the Anticancer Efficacy of Metformin
- (2009) Regan M. Memmott et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
- (2009) R. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels
- (2008) C. Diorio et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
- (2008) Pamela J. Goodwin et al. Clinical Breast Cancer
- Interaction Between Estrogen Receptor Alpha and Insulin/IGF Signaling in Breast Cancer
- (2008) Marilena Lanzino et al. CURRENT CANCER DRUG TARGETS
- Cardiovascular complications associated with biological therapies for breast cancer
- (2008) PJ Wysocki et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effect of obesity and other lifestyle factors on mortality in women with breast cancer
- (2008) Luigino Dal Maso et al. INTERNATIONAL JOURNAL OF CANCER
- Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
- (2008) Alfredo Toschi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
- (2008) Dedra H. Fagan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies: Figure 1.
- (2008) Jorge A. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis
- (2008) Weidong Zhu et al. NATURE
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Insulin receptor expression by human prostate cancers
- (2008) Michael E. Cox et al. PROSTATE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started